Immune and viral therapies for malignant primary brain tumors
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease VirusHistory and current state of immunotherapy in glioma and brain metastasis
/in Glioblastoma, International PublicationsTargeting immune checkpoints in malignant glioma
/in Checkpoint-Inhibitors, Glioblastoma, International PublicationsNovel vaccines for glioblastoma: clinical update and perspective
/in Dendritic Cells, Glioblastoma, International PublicationsAdvances in immunotherapy for the treatment of glioblastoma
/in Glioblastoma, International PublicationsMesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
/in Glioblastoma, International Publications, Newcastle Disease VirusPhase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsAdvances and challenges: dendritic cell vaccination strategies for glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsPD-1 blockade enhances the vaccination-induced immune response in glioma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer